IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2021 Holdings

Filed 2021-11-15 | 10 holdings | $239.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$182.0M643,00076.0%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$56.4M3,926,70023.6%
Alkermes PLC(ALKS)SHSG01767105$407.5K13,213,0000.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$214.1K16,390,0000.1%
Gilead Sciences Inc(GILD)COM375558103$207.3K2,967,3000.1%
Innoviva Inc(INVA)COM45781M101$110.5K6,614,0000.0%
Amarin Corp PLCSPONS ADR NEW023111206$43.4K8,500,0000.0%
Mersana Therapeutics IncCOM59045L106$40.5K4,299,2970.0%
VOR Biopharma IncCOM929033108$11.1K707,0100.0%
Regulus Therapeutics IncCOM NEW75915K200$1.3K1,851,8510.0%